Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 15 | 2025 | 2052 | 2.870 |
Why?
|
| Brain | 6 | 2025 | 1488 | 1.200 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 609 | 1.190 |
Why?
|
| Gangliosidosis, GM1 | 2 | 2025 | 19 | 1.140 |
Why?
|
| Brain Ischemia | 2 | 2022 | 399 | 0.920 |
Why?
|
| Stroke | 2 | 2023 | 1127 | 0.860 |
Why?
|
| ErbB Receptors | 2 | 2013 | 112 | 0.760 |
Why?
|
| Glioma | 2 | 2013 | 102 | 0.740 |
Why?
|
| Intestines | 1 | 2021 | 158 | 0.670 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 2053 | 0.670 |
Why?
|
| Intracranial Aneurysm | 2 | 2023 | 345 | 0.630 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 70 | 0.610 |
Why?
|
| Collagen | 1 | 2019 | 115 | 0.600 |
Why?
|
| Kyphosis | 1 | 2018 | 5 | 0.590 |
Why?
|
| Achondroplasia | 1 | 2018 | 2 | 0.590 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2018 | 4 | 0.590 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 79 | 0.580 |
Why?
|
| Spine | 1 | 2018 | 42 | 0.570 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 66 | 0.560 |
Why?
|
| Blood Vessels | 1 | 2017 | 62 | 0.560 |
Why?
|
| Hydrogels | 1 | 2018 | 110 | 0.530 |
Why?
|
| Animals | 17 | 2024 | 19650 | 0.520 |
Why?
|
| Contrast Media | 3 | 2015 | 400 | 0.520 |
Why?
|
| Biomimetics | 1 | 2014 | 28 | 0.450 |
Why?
|
| Liposomes | 1 | 2014 | 100 | 0.440 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 63 | 0.430 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 72 | 0.430 |
Why?
|
| Molecular Imaging | 1 | 2013 | 46 | 0.420 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 213 | 0.400 |
Why?
|
| Coordination Complexes | 1 | 2012 | 8 | 0.400 |
Why?
|
| Cerebral Angiography | 3 | 2023 | 280 | 0.400 |
Why?
|
| Manganese Compounds | 1 | 2012 | 7 | 0.390 |
Why?
|
| Peroxidase | 1 | 2012 | 70 | 0.390 |
Why?
|
| Chlorides | 1 | 2012 | 32 | 0.380 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 292 | 0.370 |
Why?
|
| Brain Neoplasms | 2 | 2013 | 305 | 0.370 |
Why?
|
| Tomography, Optical Coherence | 2 | 2024 | 209 | 0.360 |
Why?
|
| Tay-Sachs Disease | 2 | 2022 | 34 | 0.360 |
Why?
|
| Dogs | 2 | 2022 | 314 | 0.320 |
Why?
|
| Humans | 21 | 2025 | 59389 | 0.310 |
Why?
|
| Disease Progression | 2 | 2025 | 1119 | 0.290 |
Why?
|
| Genetic Therapy | 3 | 2024 | 733 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2023 | 275 | 0.260 |
Why?
|
| Cattle | 2 | 2019 | 304 | 0.250 |
Why?
|
| Respiration | 2 | 2017 | 88 | 0.240 |
Why?
|
| Solubility | 2 | 2018 | 177 | 0.240 |
Why?
|
| Atrophy | 1 | 2025 | 76 | 0.230 |
Why?
|
| Neurofibromin 1 | 1 | 2024 | 11 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 574 | 0.230 |
Why?
|
| Rats | 3 | 2013 | 1910 | 0.230 |
Why?
|
| Male | 10 | 2025 | 27747 | 0.230 |
Why?
|
| Neurofibromatosis 1 | 1 | 2024 | 28 | 0.230 |
Why?
|
| Codon, Nonsense | 1 | 2024 | 51 | 0.220 |
Why?
|
| Cerebral Arteries | 1 | 2024 | 39 | 0.220 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2017 | 205 | 0.220 |
Why?
|
| Female | 9 | 2025 | 30724 | 0.220 |
Why?
|
| Mice, Inbred DBA | 2 | 2014 | 84 | 0.210 |
Why?
|
| Mice | 7 | 2024 | 10294 | 0.210 |
Why?
|
| Neuroimaging | 1 | 2024 | 143 | 0.210 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2023 | 13 | 0.210 |
Why?
|
| Carotid Artery, Internal | 1 | 2023 | 66 | 0.200 |
Why?
|
| Models, Anatomic | 1 | 2023 | 60 | 0.200 |
Why?
|
| Rats, Nude | 2 | 2013 | 25 | 0.200 |
Why?
|
| Treatment Outcome | 2 | 2023 | 5281 | 0.200 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 95 | 0.200 |
Why?
|
| Infarction | 1 | 2022 | 19 | 0.190 |
Why?
|
| Mutation | 3 | 2018 | 2456 | 0.190 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1051 | 0.190 |
Why?
|
| Rabbits | 1 | 2022 | 322 | 0.190 |
Why?
|
| Radial Artery | 1 | 2022 | 49 | 0.190 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 1206 | 0.190 |
Why?
|
| Thrombectomy | 1 | 2023 | 208 | 0.180 |
Why?
|
| Demography | 1 | 2021 | 169 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 3231 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 651 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 204 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1368 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 154 | 0.170 |
Why?
|
| Oxygen | 1 | 2022 | 313 | 0.170 |
Why?
|
| Infant | 1 | 2025 | 1492 | 0.170 |
Why?
|
| Injections | 1 | 2020 | 76 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 84 | 0.170 |
Why?
|
| Thalamus | 1 | 2020 | 64 | 0.170 |
Why?
|
| Child, Preschool | 1 | 2025 | 1793 | 0.160 |
Why?
|
| Weight Loss | 1 | 2021 | 263 | 0.160 |
Why?
|
| Implants, Experimental | 1 | 2019 | 5 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 145 | 0.150 |
Why?
|
| Movement | 2 | 2017 | 149 | 0.150 |
Why?
|
| Stents | 1 | 2022 | 461 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2017 | 459 | 0.150 |
Why?
|
| Myelin Basic Protein | 1 | 2018 | 21 | 0.150 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 24 | 0.150 |
Why?
|
| Oligodendroglia | 1 | 2018 | 33 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 836 | 0.150 |
Why?
|
| Myelin Sheath | 1 | 2018 | 34 | 0.140 |
Why?
|
| Diffusion | 1 | 2017 | 82 | 0.140 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 117 | 0.140 |
Why?
|
| Luciferases | 1 | 2018 | 106 | 0.140 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 88 | 0.140 |
Why?
|
| Chelating Agents | 2 | 2018 | 46 | 0.140 |
Why?
|
| Optical Imaging | 1 | 2018 | 68 | 0.140 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 51 | 0.130 |
Why?
|
| Heart | 2 | 2017 | 274 | 0.130 |
Why?
|
| Photoacoustic Techniques | 1 | 2015 | 5 | 0.130 |
Why?
|
| Ferric Compounds | 1 | 2015 | 38 | 0.130 |
Why?
|
| Dextrans | 1 | 2015 | 45 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 679 | 0.120 |
Why?
|
| Survival Rate | 1 | 2018 | 801 | 0.120 |
Why?
|
| Child | 1 | 2025 | 4189 | 0.120 |
Why?
|
| Young Adult | 1 | 2025 | 4272 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 650 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2023 | 6071 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 96 | 0.110 |
Why?
|
| Manganese | 1 | 2014 | 24 | 0.110 |
Why?
|
| Adolescent | 1 | 2025 | 5838 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1118 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 133 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 200 | 0.110 |
Why?
|
| Gold | 1 | 2015 | 225 | 0.110 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pentetic Acid | 1 | 2012 | 32 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2012 | 76 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 241 | 0.100 |
Why?
|
| Drug Stability | 1 | 2012 | 141 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 47 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 69 | 0.100 |
Why?
|
| Dependovirus | 3 | 2024 | 652 | 0.100 |
Why?
|
| Gadolinium | 1 | 2012 | 103 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 303 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2012 | 287 | 0.090 |
Why?
|
| Horseradish Peroxidase | 1 | 2011 | 15 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 450 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 161 | 0.090 |
Why?
|
| Time Factors | 1 | 2018 | 3615 | 0.090 |
Why?
|
| Kinetics | 1 | 2012 | 751 | 0.090 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 84 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 223 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 805 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2015 | 493 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2011 | 188 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 217 | 0.080 |
Why?
|
| Adult | 1 | 2025 | 15683 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 674 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2024 | 808 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1559 | 0.070 |
Why?
|
| Abdomen | 2 | 2017 | 91 | 0.060 |
Why?
|
| Artifacts | 2 | 2017 | 125 | 0.060 |
Why?
|
| Oxadiazoles | 1 | 2024 | 4 | 0.060 |
Why?
|
| Miniaturization | 1 | 2024 | 9 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 56 | 0.060 |
Why?
|
| Microscopy | 1 | 2024 | 90 | 0.050 |
Why?
|
| X-Rays | 1 | 2022 | 45 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2023 | 77 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2022 | 21 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 35 | 0.050 |
Why?
|
| Simvastatin | 1 | 2022 | 26 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 110 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 303 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 191 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.050 |
Why?
|
| Arginine | 1 | 2022 | 110 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2022 | 72 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 88 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 174 | 0.050 |
Why?
|
| Astrocytes | 1 | 2021 | 116 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 371 | 0.040 |
Why?
|
| Mammography | 1 | 2022 | 269 | 0.040 |
Why?
|
| Sheep | 1 | 2020 | 169 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 266 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 454 | 0.040 |
Why?
|
| Cuprizone | 1 | 2018 | 3 | 0.040 |
Why?
|
| Remyelination | 1 | 2018 | 3 | 0.040 |
Why?
|
| PPAR delta | 1 | 2018 | 9 | 0.040 |
Why?
|
| Quetiapine Fumarate | 1 | 2018 | 11 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 16 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 1997 | 0.040 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 8 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2017 | 33 | 0.030 |
Why?
|
| Motion | 1 | 2017 | 56 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 863 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 181 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 216 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 64 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 292 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 66 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 182 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 1143 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1552 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 974 | 0.020 |
Why?
|